Homepage Insights News & Events News

Summit Partners sells Viroclinics-DDL to Cerba Healthcare

Work highlight
Also in: Dutch
20-12-2021
Loyens & Loeff assisted Summit Partners with the proposed sale of Viroclinics-DDL, a company which offers a broad range of virology related services in the field of non-clinical and clinical trials, clinical diagnostics, assay development and clinical trial logistics to Cerba Healthcare, a leading global player in the field of medical diagnosis
Linkedin icon Twiter icon Mail icon
Sectors & Markets
Life Sciences & Healthcare
Expertises
Corporate / M&A Transactional Tax
Linkedin icon Twiter icon Mail icon
Branding icon

Contact us

Roel Fluit
Roel Fluit
Partner
Attorney at Law
London
Konstantina Antoniou
Konstantina Antoniou
Associate
Attorney at Law
Amsterdam
Louis Lutz
Louis Lutz
Partner
Tax Adviser
Amsterdam
Sandrine Lekkerkerker
Sandrine Lekkerkerker
Senior Associate
Tax Adviser
Amsterdam
Janneke Vlake
Janneke Vlake
Associate
Attorney at Law
Amsterdam, London
Youssef  el  Harchaoui
Youssef el Harchaoui
Partner
Attorney at Law
Amsterdam
Sanjay Sewnath
Sanjay Sewnath
Associate
Attorney at Law
Rotterdam
Return to previous slide
Go to next slide
Other recent news
  • Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    20-08-2026
    Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    Our Banking & Finance, Corporate and Tax teams advised Foundever on the Luxembourg and Dutch aspects of its significant recapitalisation and refinancing transaction.
    Work highlight
  • Living Capital Partners acquires a residential portfolio in Utrecht
    18-08-2026
    Living Capital Partners acquires a residential portfolio in Utrecht
    We advised Living Capital Partners (LCP) on the equity arrangements for its acquisition of a residential complex in Utrecht from a Dutch institutional investor.
    Work highlight
  • Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    14-08-2026
    Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    Our Corporate M&A and Tax teams advised Sever Life Sciences on its disposal of Nordic Group B.V., a European specialty pharmaceutical platform to Alfasigma.
    Work highlight
Logo Loyens & Loeff
Linkedin icon
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy